JAZZ Articles, Jazz Pharmaceuticals plc - From 07/11/24

The U.S. Federal Trade Commission (FTC) recently highlighted the significant influence of pharmacy benefit managers (PBMs) on drug prices due to ma...

Cannabinoid-focused biopharmaceutical company Avicanna Inc. (TSX:AVCN) (OTCQX:AVCNF) (FSE: 0NN) announced on Thursday that it has completed the com...

Thursday, Jazz Pharmaceuticals plc (NASDAQ:JAZZ) released topline results from the Phase 2b trial evaluating the efficacy and safety...

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrade...

President Joe Biden's administration is moving to reschedule cannabis from Schedule I to Schedule III under the Controlled Substances Act (CSA)...

Roy Bingham, CEO of BDSA, anticipates substantial growth in the U.S. cannabis market, projecting sales to reach nearly $46 billion by 2028. This gr...

On May 7, a recent SEC filing unveiled that Neena M Patil, EVP & Chief Legal Officer at Jazz Pharmaceuticals (NASDAQ:JAZZ) made an insider sell...

Following President Biden’s brief mention of cannabis reform in the State of the Union speech last month and VP Kamala Harris‘s recen...

If there's love that could move the Earth, it's that of a parent towards a child. And, as the Chinese proverb says, ‘To understand your...

"Tell me and I forget, teach me and I may remember, involve me and I learn." Benjamin Franklin When it comes to the cannabis industry, one of the ...